SGMO - Sangamo Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SGMO is currently covered by 10 analysts with an average price target of $3.62. This is a potential upside of $3.22 (805%) from yesterday's end of day stock price of $0.4.

Sangamo Therapeutics's activity chart (see below) currently has 30 price targets and 50 ratings on display. The stock rating distribution of SGMO is 70% BUY, 23.33% HOLD and 6.67% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.44% with an average time for these price targets to be met of 179.08 days.

Highest price target for SGMO is $4, Lowest price target is $1, average price target is $3.62.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 12-Feb-2024. First documented stock forecast 09-Jan-2014.

Currently out of the existing stock ratings of SGMO, 21 are a BUY (70%), 7 are a HOLD (23.33%), 2 are a SELL (6.67%).

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$1.98 (194.12%)


5 months 6 days ago

0/4 (0%)

$2.19 (270.37%)


8 months 11 days ago

0/2 (0%)

$12.85 (208.94%)



$-0.02 (-1.96%)


8 months 12 days ago

2/3 (66.67%)

$0.56 (127.27%)




$0.98 (96.08%)

8 months 15 days ago

0/4 (0%)

$1.54 (334.78%)



11 months 7 days ago

1/2 (50%)

$1.04 (35.14%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SGMO (Sangamo Therapeutics) average time for price targets to be met?

On average it took 179.08 days on average for the stock forecasts to be realized with a an average price target met ratio 42.44

Which analyst has the current highest performing score on SGMO (Sangamo Therapeutics) with a proven track record?


Which analyst has the most public recommendations on SGMO (Sangamo Therapeutics)?

Gena Wang works at BARCLAYS and has 6 price targets and 3 ratings on SGMO

Which analyst is the currently most bullish on SGMO (Sangamo Therapeutics)?

Maury Raycroft with highest potential upside - $21.98

Which analyst is the currently most reserved on SGMO (Sangamo Therapeutics)?

Jim Birchenough with lowest potential downside - -$0.02

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?